CIBC World Market’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.7M | Sell |
27,626
-452
| -2% | -$200K | 0.02% | 356 |
|
|
2026
Q1 | $12.5M | Buy |
28,078
+19,945
| +245% | +$9.3M | 0.02% | 343 |
|
|
2025
Q4 | $3.69M | Sell |
8,133
-103
| -1% | -$44.4K | 0.01% | 638 |
|
|
2025
Q3 | $3.23M | Sell |
8,236
-22,558
| -73% | -$9.43M | 0.01% | 682 |
|
|
2025
Q2 | $13.7M | Buy |
30,794
+16,309
| +113% | +$7.52M | 0.03% | 317 |
|
|
2025
Q1 | $7.02M | Sell |
14,485
-988
| -6% | -$460K | 0.02% | 419 |
|
|
2024
Q4 | $6.23M | Buy |
15,473
+2,404
| +18% | +$1.11M | 0.01% | 461 |
|
|
2024
Q3 | $6.08M | Sell |
13,069
-352
| -3% | -$169K | 0.01% | 437 |
|
|
2024
Q2 | $6.29M | Buy |
13,421
+1,644
| +14% | +$714K | 0.01% | 391 |
|
|
2024
Q1 | $4.92M | Buy |
11,777
+1,386
| +13% | +$586K | 0.01% | 457 |
|
|
2023
Q4 | $4.23M | Buy |
10,391
+2,158
| +26% | +$797K | 0.01% | 453 |
|
|
2023
Q3 | $2.86M | Sell |
8,233
-4,861
| -37% | -$1.7M | 0.01% | 493 |
|
|
2023
Q2 | $4.61M | Buy |
13,094
+10,464
| +398% | +$3.53M | 0.01% | 403 |
|
|
2023
Q1 | $829K | Sell |
2,630
-1,141
| -30% | -$342K | ﹤0.01% | 794 |
|
|
2022
Q4 | $1.09M | Buy |
3,771
+399
| +12% | +$122K | ﹤0.01% | 737 |
|
|
2022
Q3 | $976K | Sell |
3,372
-944
| -22% | -$272K | ﹤0.01% | 725 |
|
|
2022
Q2 | $1.22M | Sell |
4,316
-2,306
| -35% | -$617K | ﹤0.01% | 674 |
|
|
2022
Q1 | $1.73M | Buy |
6,622
+2,713
| +69% | +$644K | 0.01% | 621 |
|
|
2021
Q4 | $858K | Buy |
+3,909
| New | +$760K | ﹤0.01% | 818 |
|
|
2021
Q2 | – | Sell |
-1,363
| Closed | -$293K | – | 1438 |
|
|
2021
Q1 | $293K | Buy |
1,363
+373
| +38% | +$81.9K | ﹤0.01% | 1102 |
|
|
2020
Q4 | $234K | Sell |
990
-1,580
| -61% | -$363K | ﹤0.01% | 1154 |
|
|
2020
Q3 | $699K | Sell |
2,570
-39
| -1% | -$10.8K | ﹤0.01% | 736 |
|
|
2020
Q2 | $757K | Sell |
2,609
-15,312
| -85% | -$4.15M | ﹤0.01% | 705 |
|
|
2020
Q1 | $4.26M | Sell |
17,921
-999
| -5% | -$229K | 0.02% | 276 |
|
|
2019
Q4 | $4.14M | Buy |
+18,920
| New | +$3.83M | 0.02% | 346 |
|
|
2019
Q2 | – | Sell |
-13,279
| Closed | -$2.44M | – | 1239 |
|
|
2019
Q1 | $2.44M | Buy |
13,279
+9,697
| +271% | +$1.79M | 0.01% | 456 |
|
|
2018
Q4 | $594K | Sell |
3,582
-500
| -12% | -$86.6K | ﹤0.01% | 739 |
|
|
2018
Q3 | $787K | Buy |
4,082
+2,762
| +209% | +$492K | ﹤0.01% | 753 |
|
|
2018
Q2 | $224K | Sell |
1,320
-533
| -29% | -$82.6K | ﹤0.01% | 1046 |
|
|
2018
Q1 | $302K | Buy |
+1,853
| New | +$303K | ﹤0.01% | 992 |
|
|
2017
Q3 | – | Sell |
-24,325
| Closed | -$3.13M | – | 1087 |
|
|
2017
Q2 | $3.13M | Buy |
+24,325
| New | +$2.93M | 0.01% | 363 |
|
|
2015
Q1 | – | Sell |
-2,880
| Closed | -$342K | – | 895 |
|
|
2014
Q4 | $342K | Buy |
+2,880
| New | +$324K | ﹤0.01% | 673 |
|
Other funds holding VRTX
CIBC World Market's VRTX Position: Q2 2026 in Review
CIBC World Market reduced its Vertex Pharmaceuticals (VRTX) stake by 1.6% in Q2 2026, selling an estimated $200K and leaving 27,626 shares worth $13.7M. The position accounts for 0.02% of the portfolio, ranked #356.
CIBC World Market first reported a position in VRTX in Q4 2014 and has held it in 32 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- CIBC World Market held 27,626 shares of Vertex Pharmaceuticals worth $13.7M as of Q2 2026.
- CIBC World Market sold 452 Vertex Pharmaceuticals shares in Q2 2026, an estimated $200K.
- Vertex Pharmaceuticals made up 0.02% of CIBC World Market's portfolio in Q2 2026, its #356 holding.
- CIBC World Market first reported a position in Vertex Pharmaceuticals in Q4 2014 and has held it in 32 quarters since.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.